Francesca Megiorni

Pubblicazioni

Titolo	Pubblicato in	Anno
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks	CELL DEATH DISCOVERY	2024
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma	BMC CANCER	2024
Polyethylene micro/nanoplastics exposure induces epithelial-mesenchymal transition in human bronchial and alveolar epithelial cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs	JOURNAL OF TRANSLATIONAL MEDICINE	2023
Sex-related factors in cardiovascular complications associated to COVID-19	BIOMOLECULES	2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma	ONCOLOGY REPORTS	2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose	FRONTIERS IN ONCOLOGY	2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo	FRONTIERS IN PHARMACOLOGY	2022
Inhibiting DNA methylation as a strategy to enhance adipose-derived stem cells differentiation. Focus on the role of Akt/mTOR and Wnt/β-catenin pathways on adipogenesis	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY	2022
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2022
Protein–protein interaction network analysis applied to DNA copy number profiling suggests new perspectives on the aetiology of Mayer–Rokitansky–Küster–Hauser syndrome	SCIENTIFIC REPORTS	2021
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc	CELLS	2021
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: Cellular, molecular and computational evidence	CANCERS	2021
Altered expression of candidate genes in Mayer–Rokitansky–Küster–Hauser syndrome may influence vaginal keratinocytes biologya. A focus on Protein Kinase X	BIOLOGY	2021
Calcineurin gamma catalytic subunit ppp3cc inhibition by mir-200c-3p affects apoptosis in epithelial ovarian cancer	GENES	2021
MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms	PLOS ONE	2021
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma	CELLS	2021
MS−275 (Entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021

Pubblicazioni

Progetti di Ricerca